Drug Database
Back to search

United Kingdom· GB-APID-44221111000001101

Ciclesonide 80micrograms/dose inhaler CFC free

A ciclesonide product containing ciclesonide, registered in United Kingdom by A A H Pharmaceuticals Ltd. The same ATC class is registered in 15 of our 19 countries.

ATC R03BA08

Checked against NHS dm+d (United Kingdom) on

Informational only — not a medical device.

SOURCE REGISTER · GBNHS dm+d (United Kingdom)normalisedCiclesonide 80micrograms/dose inhaler…ATCR03BA08REGISTER NO.GB-APID-4422111100000…PACKS LISTED1CHECKEDSeptember 13, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about ciclesonideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Ciclesonide is registered in 15 of 19 countries.

Countries holding a registration under ATC R03BA08 (ciclesonide), each read from that country’s own register.

  • This record: United Kingdom, from NHS dm+d (United Kingdom)
  • 8 of them publish a price we can compare per daily dose
Search ciclesonide products by name

Ciclesonide · ATC R03BA08

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Germany
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

NHS dm+d (United Kingdom)
Active substance
Ciclesonide
Manufacturer
A A H Pharmaceuticals Ltd
Country
United Kingdom (GB)
ATC code
R03BA08
ATC class
Ciclesonide
Defined daily dose
0.16 mg, Inhal
Reimbursed
Not published by this register
Source register
NHS dm+d (United Kingdom)
Last checked
September 13, 2026

Packs & prices · 1

  • gtin
    5025903042396

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

77 interactions on record for ciclesonide.

Graded by severity as the source publishes them — 5 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check ciclesonide against other medicinesHow interaction checks work

Ciclesonide · interactions on record

77 records

  • 5 severe
  • 42 moderate
  • 19 minor
  • 11 info

Most severe, free to view

  • DesmopressinH01BA02severe
  • CladribineL01BB04severe
  • Dinutuximab betaL01FX06severe
  • Brexucabtagene autoleucelL01XL06severe
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ciclesonide in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ciclesonide products

Authorised across Europe · EMA

The same active substance is authorised in 22 EEA countries. Names it is sold under:

  • Austria · Alvesco, Ciclesonid Genetic
  • Bulgaria · Alvesco, Алвеско
  • Cyprus · Alvesco
  • Czechia · Alvesco, Ciclesonide Glenmark
  • Germany · Alvesco, Ciclesonid Glenmark
  • Denmark · Alvesco, Ciclasonide Glenmark
  • Spain · Alvesco
  • Finland · Alvesco, Ciclesonide Glenmark
  • France · Alvesco
  • Greece · Alvesco, Ciclair
  • Croatia · Airclesio, Alvesco
  • Hungary · Alvesco, Ciclesonid Sandoz
  • Ireland · Alvesco
  • Italy · Airven, Alvesco
  • Latvia · Alvesco
  • Netherlands · Alvesco Inhalator, Ciclesonide Ace
  • Norway · Alvesco, Ciclesonide Glenmark
  • Poland · Alvesco, Cyxezon
  • Romania · Alvesco Inhaler
  • Sweden · Alvesco, Ciclesonide Glenmark
  • Slovenia · Alvesco, Cmykle
  • Slovakia · Airclesio, Alvesco

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/58e7cbc7-7436-4e67-86c3-9018c70ce93e
GET /v1/drugs/58e7cbc7-7436-4e67-86c3-9018c70ce93e?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "apid": "44221111000001101",
  "desc": "Ciclesonide 80micrograms/dose inhaler CFC free (A A H Pharmaceuticals Ltd)",
  "form": "Pressurised inhalation",
  "vpid": "9004511000001107",
  "source": "dmd",
  "vtm_id": "775240002",
  "strength": "80 microgram",
  "substance": "Ciclesonide",
  "ingredient": "Ciclesonide",
  "supplier_code": "3144701000001104"
}
API referenceMCP serverPlans

See everything about ciclesonide.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console